Total Payments
$30,875
2024 Payments
$2,365
Companies
62
Transactions
994
Medicare Patients
4,249
Medicare Billing
$337,407
Payment Breakdown by Category
Food & Beverage$21,267 (68.9%)
Other$6,100 (19.8%)
Travel$2,998 (9.7%)
Education$260.71 (0.8%)
Consulting$250.00 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,267 | 972 | 68.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,100 | 4 | 19.8% |
| Travel and Lodging | $2,998 | 8 | 9.7% |
| Education | $260.71 | 9 | 0.8% |
| Consulting Fee | $250.00 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $5,469 | 79 | $0 (2024) |
| Medtronic Vascular, Inc. | $4,621 | 26 | $0 (2019) |
| PFIZER INC. | $4,276 | 107 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $2,006 | 119 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,554 | 46 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,336 | 77 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,259 | 64 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,082 | 50 | $0 (2024) |
| Amarin Pharma Inc. | $921.00 | 47 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $725.02 | 29 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,365 | 93 | E.R. Squibb & Sons, L.L.C. ($371.35) |
| 2023 | $2,125 | 86 | Bayer Healthcare Pharmaceuticals Inc. ($225.44) |
| 2022 | $3,106 | 124 | Novo Nordisk Inc ($350.87) |
| 2021 | $2,429 | 143 | Janssen Pharmaceuticals, Inc ($354.73) |
| 2020 | $2,149 | 117 | Amarin Pharma Inc. ($413.01) |
| 2019 | $3,937 | 127 | Medtronic Vascular, Inc. ($1,519) |
| 2018 | $4,456 | 152 | Medtronic Vascular, Inc. ($1,652) |
| 2017 | $10,307 | 152 | Amgen Inc. ($3,975) |
All Payment Transactions
994 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Cardiology | ||||||
| 12/16/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/11/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.77 | General |
| Category: Cardiovascular | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $33.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: CNS | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.49 | General |
| Category: Cardiovascular | ||||||
| 11/18/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Not Applicable | ||||||
| 11/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $130.04 | General |
| Category: Diabetes Care | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | InSightec,Inc | Exablate (Device) | Food and Beverage | Cash or cash equivalent | $31.12 | General |
| Category: Neurology | ||||||
| 10/28/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Cardiology | ||||||
| 10/23/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $25.56 | General |
| 10/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: Cardiology | ||||||
| 10/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Cardiology | ||||||
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $9.98 | General |
| Category: Cardiovascular | ||||||
| 10/15/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Cardiology | ||||||
| 10/08/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $33.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/30/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Cardiology | ||||||
| 09/27/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Heart Failure | ||||||
| 09/25/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Genetic Disease | ||||||
| 09/24/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.19 | General |
| Category: Cardiovascular | ||||||
| 09/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 791 | 1,262 | $275,995 | $70,043 |
| 2022 | 6 | 963 | 1,398 | $365,760 | $88,116 |
| 2021 | 10 | 1,133 | 1,621 | $352,478 | $95,324 |
| 2020 | 11 | 1,362 | 2,047 | $364,390 | $83,923 |
Total Patients
4,249
Total Services
6,328
Medicare Billing
$337,407
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 331 | 548 | $167,770 | $50,027 | 29.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 76 | 76 | $55,480 | $11,228 | 20.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 339 | 587 | $41,740 | $6,340 | 15.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 51 | $11,005 | $2,448 | 22.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 293 | 469 | $144,175 | $44,223 | 30.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 178 | 181 | $138,455 | $25,456 | 18.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 86 | 107 | $22,710 | $6,511 | 28.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 351 | 586 | $41,020 | $6,486 | 15.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $12,185 | $3,503 | 28.8% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 27 | 27 | $7,215 | $1,938 | 26.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 273 | 400 | $131,410 | $42,233 | 32.1% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 119 | 119 | $92,625 | $20,795 | 22.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 157 | 204 | $45,943 | $14,227 | 31.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 375 | 628 | $42,435 | $7,758 | 18.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 39 | 39 | $19,320 | $5,085 | 26.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 13 | 20 | $6,720 | $1,741 | 25.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 11 | 11 | $4,862 | $1,261 | 25.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 121 | 140 | $4,188 | $930.60 | 22.2% |
| 93280 | Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report | Office | 2021 | 14 | 14 | $2,675 | $900.90 | 33.7% |
| 93793 | Anti-clotting management for patient taking warfarin | Office | 2021 | 11 | 46 | $2,300 | $392.80 | 17.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 210 | 307 | $107,143 | $26,825 | 25.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 268 | 360 | $86,040 | $18,707 | 21.7% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 94 | 94 | $70,500 | $15,792 | 22.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 395 | 665 | $43,225 | $8,892 | 20.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 31 | 31 | $16,616 | $3,774 | 22.7% |
About Dr. Ronald Bloom, M.D
Dr. Ronald Bloom, M.D is a Cardiovascular Disease healthcare provider based in Bloomfield, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548238835.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Bloom, M.D has received a total of $30,875 in payments from pharmaceutical and medical device companies, with $2,365 received in 2024. These payments were reported across 994 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($21,267).
As a Medicare-enrolled provider, Bloom has provided services to 4,249 Medicare beneficiaries, totaling 6,328 services with total Medicare billing of $337,407. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Bloomfield, CT
- Active Since 03/10/2006
- Last Updated 09/16/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1548238835
Products in Payments
- Repatha (Biological) $4,718
- ELIQUIS (Drug) $4,050
- XARELTO (Drug) $2,002
- JARDIANCE (Drug) $1,002
- Vascepa (Drug) $921.00
- Corlanor (Drug) $727.60
- ENTRESTO (Drug) $685.23
- Livalo (Drug) $595.70
- CHANTIX (Drug) $515.04
- PRADAXA (Drug) $508.31
- VYNDAQEL (Drug) $505.04
- BRILINTA (Drug) $474.80
- NEXLETOL (Drug) $460.87
- Kerendia (Drug) $436.69
- LEQVIO (Drug) $396.74
- MULTAQ (Drug) $393.19
- FARXIGA (Drug) $373.09
- CAMZYOS (Drug) $371.35
- WATCHMAN Access System (Device) $362.72
- Ozempic (Drug) $361.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Bloomfield
Brett Nowlan, Md, MD
Cardiovascular Disease — Payments: $951,843
Cardiovascular Disease $951,843
Dr. Alan Lapa, M.d, M.D
Cardiovascular Disease — Payments: $28,329
Cardiovascular Disease $28,329
Tracy Patel, M.d, M.D
Cardiovascular Disease — Payments: $13,103
Cardiovascular Disease $13,103
Vincent Romano, M.d, M.D
Cardiovascular Disease — Payments: $11,581
Cardiovascular Disease $11,581
Dr. Catalino Delacruz, M.d, M.D
Cardiovascular Disease — Payments: $10,399
Cardiovascular Disease $10,399
Maria Santos, M.d, M.D
Cardiovascular Disease — Payments: $10,382
Cardiovascular Disease $10,382